UK Veterinary Medicines Directorate Suspends Injectable Flunixin Sales
- Topics: Basic Care, Horse Care, Medications, Welfare and Industry
The United Kingdom’s Veterinary Medicines Directorate (VMD) announced July 26 that it has suspended the sale of a number of drugs in that country, including the non-steroidal anti-inflammatory drug flunixin, which is commonly used in horses.
“The VMD has suspended products for food-producing animals that contain the excipient diethanolamine (DEA),” the agency said in a statement on its website. “The VMD has done this in the light of the scientific opinion of the Committee for Medicinal Products for Veterinary Use (the scientific advisory committee to the European Medicines Agency) that there may be a risk to humans from consuming food from animals treated with products containing DEA.”
A full list of suspended products is included below
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with
